Hinge Health, Inc. (HNGE) Stock Forecast
HNGE analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.47 / 5 from 17 analysts
- Price target
- $112.12 average of analyst targets
- Upside to target
- +13.1% from the latest close
- Next earnings
- November 2, 2026 EPS estimate $0.27
- 52-week range
- $31.17 – $105.14
HNGE analyst ratings
17 analystsNumber of analysts at each rating.
HNGE price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
HNGE earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.60 | $0.56 | $0.69 | $0.44 | +35.8% | 13 |
| Current fiscal year (2026) | $2.40 | $2.24 | $3.39 | $2.62 | −8.4% | 14 |
| Next fiscal year (2027) | $3.06 | $2.66 | $4.64 | $2.40 | +27.4% | 13 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
HNGE revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $224.8M | $223.2M | $229.8M | +45.8% | 14 |
| Current fiscal year (2026) | $860.6M | $856.2M | $876.7M | +46.4% | 16 |
| Next fiscal year (2027) | $1.09B | $1.04B | $1.17B | +26.5% | 15 |
HNGE EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
HNGE revenue: reported and forecast
HNGE EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.68 | $0.61 | $0.60 | $0.60 | $0.60 | −12.6% | 0 up · 1 down |
| Current fiscal year (2026) | $2.60 | $2.43 | $2.40 | $2.40 | $2.40 | −7.7% | 0 up · 1 down |
| Next fiscal year (2027) | $3.40 | $3.13 | $3.06 | $3.06 | $3.06 | −10.1% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
HNGE earnings surprises
Reported EPS vs the consensus estimate for the last 6 quarters; HNGE beat in 5 of 5.
What analysts expect from HNGE
17 analysts cover Hinge Health; their consensus rating is buy (4.47 on a 1–5 scale, where 5 is a strong buy). The average price target is $112.12, 13.1% above the latest close of $99.16. Analysts expect earnings of $2.40 per share for 2026, −8.4% from a year earlier. For 2027 the average estimate is $3.06 per share on revenue of $1.1 billion. Hinge Health beat the EPS estimate in 5 of the last 5 quarters.
Related: HNGE income statement, HNGE key metrics, HNGE chart. See the HNGE stock overview for the latest quote and news.
HNGE forecast FAQ
What is Hinge Health's price target?
The average analyst price target for Hinge Health is $112.12, 13.1% above the latest close of $99.16.
Is Hinge Health a buy, hold or sell?
Of 17 analysts covering Hinge Health, 9 rate it a strong buy, 7 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Hinge Health's EPS forecast?
Analysts forecast $2.40 per share for 2026 (range $2.24 to $3.39); for 2027 the estimate is $3.06.
What is Hinge Health's revenue forecast?
The average revenue estimate for 2026 is $860.6 million, growth of 46.4%; for 2027 it is $1.1 billion.
When does Hinge Health report earnings?
Hinge Health is expected to report results for the quarter ending September 30, 2026 on November 2, 2026 after the market closes; the EPS estimate is $0.27.
Does Hinge Health usually beat earnings estimates?
Hinge Health reported EPS at or above the analyst estimate in 5 of the last 5 quarters.